Chromium level in prediction of diabetes in pre-diabetic patients


1 Islamic Azad University, Najafabad, Iran

2 Acquired Immunodeficiency Research Center, Isfahan University of Medical, Isfahan, Iran

3 Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical, Isfahan, Iran

4 Isfahan University of Medical Sciences, Isfahan, Iran


Background: Chromium supplementations (Cr) have been shown to exert beneficial effects in the management of type-2 diabetes. Prevalence of Cr deficiency in pre-diabetic patients is not well-understood, therefore, the aim of this study was to evaluate the extent of this prevalence.
Materials and Methods: In this cross-sectional descriptive study, 132 pre-diabetic patients were recruited. The participants were randomly selected from those who referred to the Shariati Hospital in Isfahan, Iran. Blood samples are collected for measurement of Cr, insulin, fasting blood sugar (FBS), and two-hour post-load plasma glucose. The body mass index (BMI) was calculated. Determination of Cr was carried out by atomic absorption spectrometry.
Results: Thirty-four (31.5%) patients had Cr deficiency and 74 (68.5%) patients had normal Cr. There was no significant difference between sex, age groups (<50 years and ≥50 years) and between patients with and without a family history of diabetes in both the groups. No significant differences in age, BMI, FBS or insulin were observed between two groups. In the group with a normal level of Cr, there was a significant reversed correlation between the Cr level and age, but no significant correlation existed between the Cr level and other factors in both groups.
Conclusion: The levels of Cr deficiency are relatively common in patients with pre-diabetes, and it is necessary to screen patients with diabetes and pre-diabetes according to the American Diabetes Association guidelines, with regard to the Cr level and action should be taken to eliminate the Cr deficiency in these patients.


Sicree R, Shaw JE, Zimmet PZ. The global burden of diabetes. In: Gan D, editor. Diabetes Atlas. 2 nd ed. Brussels, Belgium: International Diabetes Federation;2003. p. 15-71.  Back to cited text no. 1
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl 1):S62-7.   Back to cited text no. 2
Ali A, Ma Y, Reynolds J, Wise JP Sr, Inzucchi SE, Katz DL. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus. Endocr Pract 2011;17:16-25.  Back to cited text no. 3
Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol 2009;3:500-8.  Back to cited text no. 4
Padwal R, Majumdar SR, Johnson JA, Varney J, McAlister FA. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care 2005;28:736-44.   Back to cited text no. 5
Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29:1997-2002.   Back to cited text no. 6
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.   Back to cited text no. 7
Afridi HI, Kazi TG, Brabazon D, Naher S, Talpur FN. Comparative metal distribution in scalp hair of Pakistani and Irish referents and diabetes mellitus patients. Clin Chim Acta 2013;415:207-14.   Back to cited text no. 8
Wang YQ, Yao MH. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK. J Nutr Biochem 2009;20:982-91.  Back to cited text no. 9
Kwon MJ, Chung HS, Yoon CS, Ko JH, Jun HJ, Kim TK, et al. The effect of chromium on rat insulinoma cells in high glucose conditions. Life Sci 2010;87:401-4.  Back to cited text no. 10
Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG.Effect of chromium supplementation on glucose metabolism and lipids: A systematic review of randomized controlled trials. Diabetes Care 2007;30:2154-63.  Back to cited text no. 11
Vincent JB. The Nutritional Biochemistry of Chromium (III). Amsterdam,Boston: Elsevier; 2007.  Back to cited text no. 12
Phillips LS, Weintraub WS, Ziemer DC, Kolm P, Foster JK, Vaccarino V, et al. All pre-diabetes is not the same: Metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: The screening for impaired glucose tolerance study 1 (SIGT 1). Diabetes Care 2006;29:1405-7.  Back to cited text no. 13
Nawrocka A, Szkoda J. Determination of chromium in biological material by electrothermal atomic absorption spectrometry method. Bull Vet Inst Pulawy 2012;56:585-9.  Back to cited text no. 14
Mertz W, Toepfer EW, Roginski EE, Polansky MM. Present knowledge of the role of chromium. Fed Proc 1974;33:2275-80.  Back to cited text no. 15
Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 1997;36:4382-5.  Back to cited text no. 16
Gunton JE, Hams G, Hitchman R, McElduff A. Serum chromium does not predict glucose tolerance in late pregnancy. Am J Clin Nutr 2001;73:99-104.  Back to cited text no. 17
Anderson RA.Stress effects on chromium nutrition of humans and farm animals. In: Anonymous,editor.Proceedings of Alltech's Tenth Symposium on Biotechnology in the Feed Industry. Nottingham, England: University Press;1994.p. 267-74.  Back to cited text no. 18
Anderson RA.Recent advances in the clinical and biochemical effects of chromium deficiency. In: Prasad AS,editor.Essential and Toxic Trace Elements in Human Health and Disease. New York: Wiley Liss;1993.p. 221-34.  Back to cited text no. 19
Tripathy S, Sumathi S, Raj GB. Minerals nutritional status of type 2 diabetic subjects. Int J Diab Dev Countries 2004;24:27-8.  Back to cited text no. 20
Cefalu WT, Rood J, Pinsonat P, Qin J, Sereda O, Levitan L,et al. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010;59:755-62.  Back to cited text no. 21
Campbell WW, Joseph LJ, Anderson RA, Davey SL, Hinton J, Evans WJ.Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women. Int J Sport Nutr Exerc Metab 2002;12:125-35.  Back to cited text no. 22
Ding W, Chai Z, Duan P, Feng W, Qian Q. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 1998;63:231-7.  Back to cited text no. 23
Ravina A, Slezack L. Chromium in the treatment of clinical diabetes mellitus. IMAJ 1993;125:142-5, 191.  Back to cited text no. 24
Duncan MG. The effects of nutritional supplements on the treatment of depression, diabetes, and hypercholesterolemia in the renal patient. J Ren Nutr 1999;9:58-62.  Back to cited text no. 25